Figure 2.
Survival curves for PLK1 in CRC. Kaplan–Meier survival curve showing no significant difference in (A) disease-free survival (p = 0.7114), (B) recurrence-free survival (p = 0.1240), (C) overall survival (p = 0.2923), and (D) cancer-specific survival (p = 0.3969) were compared between cases with high PLK1 expression and cases with low PLK1 expression.